NEWEarnings

Syndax Pharmaceuticals Inc (SNDX) Files Form 144 on June 1

Published on 6/1/2026

#SNDX#Form144#insiderTrading
Syndax Pharmaceuticals Inc (SNDX) Files Form 144 on June 1

AI Summary

Syndax Pharmaceuticals Inc (SNDX) submitted Form 144 on June 1. This filing indicates the potential sale of shares, typically performed by insiders or affiliates. Such filings can affect investor perception, as they may suggest insider selling, which can influence market behavior. The document's specifics and the number of shares registered have not been disclosed, making it difficult to ascertain the immediate impact on SNDX stock prices.

Source: Read original article (opens in new tab)

Related News

Form 144 Filed by STANDARD MOTOR PRODUCTS on June 1
Markets

Form 144 Filed by STANDARD MOTOR PRODUCTS on June 1

Jun 1

Oklo Inc. (OKLO) Files Form 144 for June 1 Share Sale
Markets

Oklo Inc. (OKLO) Files Form 144 for June 1 Share Sale

Jun 1

Franklin Financial Services (FRAF) EVP Steven Butz Sells $80,822 in Stock
Markets

Franklin Financial Services (FRAF) EVP Steven Butz Sells $80,822 in Stock

Jun 1

Veracyte (VCYT) stock target raised to $57 based on trial data
Earnings

Veracyte (VCYT) stock target raised to $57 based on trial data

Jun 1